This item requires a subscription toJournal of Clinical Oncology Online.

Full Text EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin... Sobrero et al. J Clin Oncol.2008; 26: 2311-2319 To view this item, select one of the options below: Sign In User Name Sign in without cookies. Can't get past this page? Help with Cookies. Need to Activate? Password Remember my user name & password. Forgot your user name or password? Athens Users Sign in via Athens: Access is available using your Athens username and password. Contact your library if you do not have an Athens username and password. List of Athens registered sites, including contact details. Sign Up Subscribe to the Journal - Subscribe to the print and/or online journal. Order Online - Purchase your subscription online. [regain access to your recent online order] Renew Online - Renew your subscription online. [regain access to your recent online renewal] Purchase JCO Legacy Archive - [More Information] [regain access to your recent online Legacy Archive order]

This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Google Scholar Articles by Sobrero, A. F. Articles by Burris, H. A. PubMed PubMed Citation Articles by Sobrero, A. F. Articles by Burris, H. A., III